115 related articles for article (PubMed ID: 10360316)
1. The ketolide antibiotic HMR 3647, a candidate substance for the treatment of systemic and intracerebral infections with Listeria monocytogenes.
Nichterlein T; Kretschmar M; Hof H
Zentralbl Bakteriol; 1999 Apr; 289(2):155-64. PubMed ID: 10360316
[TBL] [Abstract][Full Text] [Related]
2. Systemic and intracerebral infections of mice with Listeria monocytogenes successfully treated with linezolid.
Callapina M; Kretschmar M; Dietz A; Mosbach C; Hof H; Nichterlein T
J Chemother; 2001 Jun; 13(3):265-9. PubMed ID: 11450884
[TBL] [Abstract][Full Text] [Related]
3. Clinafloxacin (CL 960) is superior to standard therapeutics in the treatment of murine listeriosis and salmonellosis.
Nichterlein T; Bornitz F; Kretschmar M; Hof H
Zentralbl Bakteriol; 1997 Oct; 286(3):401-12. PubMed ID: 9361386
[TBL] [Abstract][Full Text] [Related]
4. Bay Y 3118, a new quinolone derivative, rapidly eradicates Listeria monocytogenes from infected mice and L929 cells.
Nichterlein T; Kretschmar M; Budeanu C; Bauer J; Linss W; Hof H
Antimicrob Agents Chemother; 1994 Jul; 38(7):1501-6. PubMed ID: 7979279
[TBL] [Abstract][Full Text] [Related]
5. In-vitro activity of the new ketolide antibiotic HMR 3647 against gram-positive bacteria.
Schülin T; Wennersten CB; Moellering RC; Eliopoulos GM
J Antimicrob Chemother; 1998 Sep; 42(3):297-301. PubMed ID: 9786468
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of ketolide HMR 3647, macrolides, and clindamycin against Coryneform bacteria.
Martínez-Martínez L; Pascual A; Suárez AI; Perea EJ
Antimicrob Agents Chemother; 1998 Dec; 42(12):3290-2. PubMed ID: 9835530
[TBL] [Abstract][Full Text] [Related]
7. The ketolide antibiotics HMR 3647 and HMR 3004 are active against Toxoplasma gondii in vitro and in murine models of infection.
Araujo FG; Khan AA; Slifer TL; Bryskier A; Remington JS
Antimicrob Agents Chemother; 1997 Oct; 41(10):2137-40. PubMed ID: 9333038
[TBL] [Abstract][Full Text] [Related]
8. RP 59500, a streptogramin derivative, is effective in murine listeriosis.
Nichterlein T; Kretschmar M; Hof H
J Chemother; 1996 Apr; 8(2):107-12. PubMed ID: 8708741
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic properties of HMR 3647, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time-kill kinetics and postantibiotic effect.
Boswell FJ; Andrews JM; Wise R
J Antimicrob Chemother; 1998 Feb; 41(2):149-53. PubMed ID: 9533455
[TBL] [Abstract][Full Text] [Related]
10. Comparative in-vitro activity of ketolide HMR 3647 and four macrolides against gram-positive cocci of known erythromycin susceptibility status.
Hamilton-Miller JM; Shah S
J Antimicrob Chemother; 1998 Jun; 41(6):649-53. PubMed ID: 9687104
[TBL] [Abstract][Full Text] [Related]
11. The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent.
Boswell FJ; Andrews JM; Ashby JP; Fogarty C; Brenwald NP; Wise R
J Antimicrob Chemother; 1998 Dec; 42(6):703-9. PubMed ID: 10052892
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of murine listeriosis and salmonellosis with levofloxacin.
Nichterlein T; Bornitz F; Kretschmar M; Hof H
J Chemother; 1998 Aug; 10(4):313-9. PubMed ID: 9720471
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae.
Barry AL; Fuchs PC; Brown SD
Eur J Clin Microbiol Infect Dis; 1997 Oct; 16(10):767-9. PubMed ID: 9405952
[TBL] [Abstract][Full Text] [Related]
14. Comparative antimicrobial activity and kill-curve investigations of novel ketolide antimicrobial agents (HMR 3004 and HMR 3647) tested against Haemophilus influenzae and Moraxella catarrhalis strains.
Biedenbach DJ; Barrett MS; Jones RN
Diagn Microbiol Infect Dis; 1998 Jun; 31(2):349-53. PubMed ID: 9635909
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens.
Denis A; Agouridas C; Auger JM; Benedetti Y; Bonnefoy A; Bretin F; Chantot JF; Dussarat A; Fromentin C; D'Ambrières SG; Lachaud S; Laurin P; Le Martret O; Loyau V; Tessot N; Pejac JM; Perron S
Bioorg Med Chem Lett; 1999 Nov; 9(21):3075-80. PubMed ID: 10560728
[TBL] [Abstract][Full Text] [Related]
16. In vitro pharmacodynamic studies of activities of ketolides HMR 3647 (Telithromycin) and HMR 3004 against extracellular or intracellular Helicobacter pylori.
Gustafsson I; Engstrand L; Cars O
Antimicrob Agents Chemother; 2001 Jan; 45(1):353-5. PubMed ID: 11120997
[TBL] [Abstract][Full Text] [Related]
17. HMR 3647 human-like treatment of experimental pneumonia due to penicillin-resistant and erythromycin-resistant Streptococcus pneumoniae.
Piroth L; Desbiolles N; Mateo-Ponce V; Martin L; Lequeu C; Charles PE; Portier H; Chavanet P
J Antimicrob Chemother; 2001 Jan; 47(1):33-42. PubMed ID: 11152429
[TBL] [Abstract][Full Text] [Related]
18. Comparative activities of macrolide derivatives on murine listeriosis.
Bauer J; Hof H; Nichterlein T; Wuenscher M
Zentralbl Bakteriol; 1993 Feb; 278(1):112-9. PubMed ID: 8518506
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of HMR 3647 against anaerobic bacteria.
Edlund C; Sillerström E; Wahlund E; Nord CE
J Chemother; 1998 Aug; 10(4):280-4. PubMed ID: 9720465
[TBL] [Abstract][Full Text] [Related]
20. The bactericidal activities of HMR 3004, HMR 3647 and erythromycin against gram-positive bacilli and development of resistance.
Fernández-Roblas R; Calvo R; Esteban J; Bryskier A; Soriano F
J Antimicrob Chemother; 1999 Feb; 43(2):285-9. PubMed ID: 11252337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
